月度归档： 2026 年 8 月

Receptor.AI and Sethera partner to create a closed-loop drug discovery workflow. Sethera will generate and experimentally screen architecture-diverse polymacrocyclic peptide libraries. Receptor.AI will apply physics-based modeling, artificial intelligence, and multiparameter optimization to interpret sequence, architecture, enrichment, and activity data; develop binding hypotheses; prioritize candidate series; and guide focused optimization cycles.

Why it matters: The transaction would rank among the largest pharmaceutical deals ever and create the world’s fourth-largest drugmaker by market value. It would also represent a sharp strategic turn for AstraZeneca, which has spent the past decade building its pipeline through targeted acquisitions and licensing deals rather than another industry-defining merger.

世界农化网中文网报道：当地时间2026年7月30日，中农立华国际业务旗下SINO-AGRI Argentina品牌暨新品发布会在阿根廷罗萨里奥举办。本次盛会是继2023年杭州全球品牌焕新首发后，在南美市场持续推进品牌建设与本地化运营的重要一步。通过此次发布会，公司进一步展示了在产品开发、登记布局、供应链管理和市场服务等方面的综合能力，并明确了以阿根廷为重要支点，持续深化南美市场发展的长期方向。

After seeing its lead candidate rejected by the FDA last year, Capricor Therapeutics (Nasdaq: CAPR) is hoping for a better outcome for its resubmitted biologics license application (BLA) for its lead pipeline candidate Deramiocel, a cell therapy indicated as a treatment for cardiomyopathy in Duchenne muscular dystrophy (DMD).

[Disclosure: AgFunderNews’ parent company AgFunder is an investor in Plantik Biosciences.] Can editing the so-called “da…

世界农化网中文网报道：近日，富美实（FMC）在圣保罗举行的Coopercitrus Expo 2026上正式发布新型柑橘杀菌剂Onsuva®。该产品含FMC自有活性成分fluindapyr（氟茚唑菌胺），此前已在大豆、玉米和棉花的主要病害管理中建立应用基础，此次拓展至柑橘作物。

近几年，农药行业迎来新一轮专利解禁潮，多个市场反馈优异、防治效果突出的核心有效成分已逐渐脱离原研企业的专利保护期，为国内企业打开了新的进入窗口。

Could water be the key that unlocks the potential of plant-based fats?Canada’s Botaneco has devised a process that unites two historically unfriendly ingredients – water and oil – to create next-generation fat alternatives.

To bring its functional ingredient solutions to an Indian market increasingly hungry for them, Lucknow-based Arboreal Bioinnovations has closed a major funding round.